Loading clinical trials...
Loading clinical trials...
Clinical and Basic Investigations into Phosphomannomutase deficiency (PMM2-CDG) This is a natural history (observational) protocol designed to collect clinical and biological information in patients ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Glycomine, Inc.
NCT06892288 · Phosphomannomutase 2 Deficiency, PMM2-CDG
NCT05549219 · Pmm2-CDG, Phosphomannomutase 2 Deficiency
Mayo Clinic College of Medicine
Rochester, Minnesota
Children's Hospital of Philadelphia (CHOP)
Philadelphia, Pennsylvania
Seattle Children's Hospital
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions